The Harvard Medical School Family Health Guide
Heart, Blood Vessels, and Circulation
Harvard Health Publications
Order the Book
Contact Us
Sign up for our free e-mail newsletter, HEALTHbeat.  
Email Address:
First Name (optional):
Special Health Information Reports
Weight Loss
Prostate Disease
Vitamins and Minerals
Aching Hands
See All Titles
Browse Health Information
Common Medical Conditions
Wellness & Prevention
Emotional Well Being & Mental Health
Women’s Health
Men’s Health
Heart & Circulatory Health
About the Book
New Information
About the Team
Order the Book
Return to the Family Health Guide Home Page
  Harvard Health Publications
contact us

Diseases of the Heart Valves

Return to Chapter Index

Aggressive Therapy for Older Hearts

There's no question coronary artery bypass grafting and angioplasty can relieve the pain of angina, prevent heart attacks, and add years to the lives of people with blocked coronary arteries. But most studies have excluded people over age 70, so the benefits of aggressive therapy is less clear in the older patient.

Two studies from Switzerland and Canada provide good news for older people who may need bypass surgery or angioplasty. Swiss researchers compared the effects of medical therapy and invasive therapy among more than 300 men and women with angina, all of whom were age 75 or over. They reported the results in the journal Lancet. After six months, the frequency and severity of chest pain had lessened and the quality of life had improved in both groups. But the improvements were substantially greater, and the heart attack rate substantially lower, among those who had undergone bypass surgery or angioplasty.

The Canadian study, which appeared in the Canadian Medical Association Journal, compared the effects of bypass surgery on patients in their 80s and those in their 70s. The investigators found it as safe and effective for octogenarians as it was for septuagenarians and reported that it cost about the same in either group.

Neither of these studies provides blanket assurance that an invasive procedure like bypass surgery or angioplasty is right for every older person with blocked coronary arteries. Older candidates for bypass surgery or angioplasty may want to focus on quality-of-life issues. Recovery, for example, may be a completely different experience for older people.
December 2001 Update

Back to Top

Update on Fen-Phen and Heart-Valve Problems

Two recent studies are adding to the data concerning fen-phen and heart-valve problems. These studies should offer some reassurance to patients who took this combination of weight-loss drugs.

Researchers from Harvard Medical School evaluated echocardiograms performed on 226 people who took fen-phen as part of a long-term study from September 1994 to September 1997. Shortly after the manufacturer’s voluntary withdrawal of fen-phen, the medications were stopped and the patients underwent testing to determine if any heart-valve problems had developed. The echocardiograms showed that not one patient had severe valvular disease. Mild leaking of the aortic valve was detected in 12 patients, and three patients exhibited moderate aortic-valve leaking — a total of 15 (6.6%) patients. Three subjects (1.3%) had moderate leaking of the mitral valve. To compare the rate of heart-valve problems in these patients to the rate one might expect to see in the general population, investigators turned to data collected as part of the Framingham Heart Study (the long-term epidemiological study being conducted in a Boston suburb). They found nearly the same rates of aortic- and mitral-valve leaking in the Framingham volunteers as in the diet-drug study participants.

A second study published in the November 23, 1999, issue of the American Heart Association journal, Circulation, suggests that heart-valve abnormalities in individuals who took dexfenfluramine (Redux) may dissipate. Although study findings did link the drug to mild aortic-valve disease and moderate mitral-valve problems, it also noted that valve problems might eventually go away after drug use is stopped.

Using echocardiograms to spot heart-valve abnormalities, investigators evaluated 223 patients who had taken dexfenfluramine for an average of seven months. The tests were performed an average of 8.5 months after the participants stopped taking the drug. None of the former dexfenfluramine users was found to have severe mitral valve disease or moderate (or worse) aortic-valve disease, but 7.6% had either mild aortic-valve disease or moderate mitral-valve problems. People who had stopped treatment less than eight months before the echocardiogram were twice as likely to have valve problems than those who had been off dexfenfluramine for longer, suggesting the problem regresses.

Could it be that these diet pills are safe after all? An editorial in the Journal of the American College of Cardiology accompanied publication of the Harvard study and asked whether there was adequate proof of any increase in risk from fen-phen. No one is ready to go so far as to suggest that these drugs should return to the market, but a reasonable conclusion at this point is that there is an increased risk of heart-valve problems, though the risk is probably quite small.

Regardless of the relative risks and merits of fen-phen — and of diet drugs in general — weight loss remains a problem that cannot be solved by any "magic bullet." Medications may help a little in some patients, and surgical solutions might be considered for severely overweight individuals. However, for most of us, regular exercise and careful attention to how many calories we eat remain the best strategies for successful and lasting weight loss.

Journal of the American College of Cardiology, Vol. 34, No. 4, pp. 1153–58.
Circulation, Vol. 100, No. 21, pp. 2161–67.

Back to Top

©2000–2006 President & Fellows of Harvard College
Sign Up Now For
Our FREE E-mail Newsletter

In each weekly issue of HEALTHbeat:

  • Get trusted advice from the doctors at Harvard Medical School
  • Learn tips for living a healthy lifestyle
  • Stay up-to-date on the latest developments in health
  • Plus, receive your FREE Bonus Report, Living to 100: What's the secret?

[ Maybe Later ] [ No Thanks ]